Trial Profile
A Randomised, Multi-centre, Double-blind, Active-controlled, Parallel Group Study to Assess the Efficacy and Safety of Modified Release Prednisone (Lodotra) Compared to Immediate Release Prednisone (Prednisone IR) in Subjects Suffering From Polymyalgia Rheumatica (PMR)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Prednisone (Primary)
- Indications Polymyalgia rheumatica
- Focus Registrational; Therapeutic Use
- Sponsors Mundipharma Research
- 08 Feb 2019 This trial has been discontinued in United Kingdom, according to European Clinical Trials Database.
- 01 Apr 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 Feb 2014 Status changed from recruiting to active, no longer recruiting reported by ClinicalTrials.gov record.